TMCI
Treace Medical Concepts Inc
3.90$
-0.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23.3% | 0.9% | -14.1% | -31.3% | -26.3% | -6.1% | 8.0% | -6.4% | -18.1% | -12.8% | 15.3% | -10.4% | -7.1% | |
| 3.8% | 2.8% | 3.7% | 4.8% | 4.8% | 3.3% | 4.7% | 5.2% | 5.5% | 4.6% | 1.9% | 4.2% | 4.1% | |
| 12.7% | 9.4% | 14.5% | 15.2% | 17.5% | 12.5% | 16.5% | 20.2% | 15.9% | 12.1% | 17.0% | 14.2% | 14.6% | |
| 1.9% | -2.4% | 3.0% | -8.9% | -13.3% | -24.8% | 14.7% | 3.1% | -9.3% | -21.0% | 31.2% | 2.5% | -0.9% | |
| 8.6% | 3.6% | 7.7% | 3.9% | 6.4% | 4.5% | 6.7% | 10.1% | 5.6% | 3.8% | 6.5% | 4.9% | 5.1% | |
| 11.3% | 8.0% | 7.4% | 50.5% | 12.8% | 5.0% | -3.6% | -6.9% | 17.4% | 15.5% | -16.6% | 15.6% | 8.6% | |
| – | 0.0% | -0.5% | – | 0.5% | – | – | – | -0.8% | – | – | – | – | |
| 0.4% | 0.3% | -0.4% | 0.7% | 0.0% | 0.0% | -0.5% | 2.1% | 0.0% | 2.2% | -1.2% | 1.5% | 0.7% | |
| -11.7% | 9.2% | -7.1% | 19.9% | -13.5% | -1.1% | 3.8% | -11.2% | -0.7% | 4.8% | -2.5% | 6.8% | 2.2% | |
| -31.9% | -2.8% | -21.8% | -35.2% | -32.6% | -10.6% | 1.2% | -16.5% | -23.7% | -16.7% | 8.8% | -15.2% | -12.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.